All In Biotech

Drug Trial Radar · NCT03514641

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin Tablets, 20 mg, for the Management of Essential Hypertension

Last checked: Nov 20, 2026Latest source record: Sep 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 673 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

673

Actual

Start

Oct 18, 2017

Primary completion

Nov 30, 2018

Study completion Nov 30, 2018

Sponsor

Lead sponsor
TheracosIndustry
Sponsor type
Industry
First posted
May 2, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.

Conditions

  • Essential Hypertension

Interventions

  • BexagliflozinDrug

    Bexagliflozin tablet, 20 mg

  • PlaceboDrug

    Placebo (inactive) tablet to match the active drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of the 24 Hour Mean Systolic Blood Pressure From Baseline (Day 1) to Week 12Time frame: Baseline (Day 1) to week 12
  2. Change of the 24 Hour Mean Systolic Blood Pressure From Cumulative Week 24 to Week 36Time frame: Change from week 24 to week 36

Locations

87 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Site

    Birmingham, Alabama

  • Clinical Research Site

    Birmingham, Alabama

  • Clinical Research Site

    Birmingham, Alabama

  • Clinical Research Site

    Foley, Alabama

  • Clinical Research Site

    Gulf Shores, Alabama

  • Clinical Research Site

    Glendale, Arizona

  • Clinical Research Site

    Mesa, Arizona

  • Clinical Research Site

    Phoenix, Arizona

  • Clinical Research Site

    Tucson, Arizona

  • Clinical Research Site

    Anaheim, California

  • Clinical Research Site

    Bellflower, California

  • Clinical Research Site

    Fair Oaks, California

  • Clinical Research Site

    Fresno, California

  • Clinical Research Site

    Lincoln, California

  • Clinical Research Site

    Los Angeles, California

  • Clinical Research Site

    San Gabriel, California

  • Clinical Research Site

    Santa Rosa, California

  • Clinical Research Site

    Upland, California

  • Clinical Research Site

    Colorado Springs, Colorado

  • Clinical Research Site

    Colorado Springs, Colorado

  • Clinical Research Site

    Denver, Colorado

  • Clinical Research Site

    Golden, Colorado

  • Clinical Research Site

    Stamford, Connecticut

  • Clinical Research Site

    Decatur, Georgia

  • Clinical Research Site

    Decatur, Georgia

  • Clinical Research Site

    Lithonia, Georgia

  • Clinical Research Site

    Chicago, Illinois

  • Clinical Research Site

    Chicago, Illinois

  • Clinical Research Site

    Chicago, Illinois

  • Clinical Research Site

    Avon, Indiana

  • Clinical Research Site

    Evansville, Indiana

  • Clinical Research Site

    Indianapolis, Indiana

  • Clinical Research Site

    Council Bluffs, Iowa

  • Clinical Research Site

    Prairie Village, Kansas

  • Clinical Research Site

    Lexington, Kentucky

  • Clinical Research Site

    Paducah, Kentucky

  • Clinical Research Site

    Versailles, Kentucky

  • Clinical Research Site

    New Orleans, Louisiana

  • Clinical Research Site

    Auburn, Maine

  • Clinical Research Site

    Silver Spring, Maryland

Showing 40 of 87 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.